227 related articles for article (PubMed ID: 37778627)
21. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
DeGregorio GA; Singer J; Cahill KN; Laidlaw T
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
[TBL] [Abstract][Full Text] [Related]
22. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
23. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
[TBL] [Abstract][Full Text] [Related]
24. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
Simon RA; Dazy KM; Waldram JD
Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
[TBL] [Abstract][Full Text] [Related]
25. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
Mullol J; Picado C
Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
[TBL] [Abstract][Full Text] [Related]
26. Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Buchheit KM; Hacker J; Maurer R; McGill A; Ryan T; Bensko JC; Laidlaw TM
Clin Exp Allergy; 2023 Sep; 53(9):974-977. PubMed ID: 37246613
[No Abstract] [Full Text] [Related]
27. Management of United Airway Disease Focused on Patients With Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
Mullol J; Maldonado M; Castillo JA; Miguel-Blanco C; Dávila I; Domínguez-Ortega J; Blanco-Aparicio M
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2438-2447.e9. PubMed ID: 35568331
[TBL] [Abstract][Full Text] [Related]
28. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
Simon RA; Dazy KM; Waldram JD
Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
[TBL] [Abstract][Full Text] [Related]
29. A Review of Aspirin-exacerbated Respiratory Diseases and Immunological Efficacy of Aspirin Desensitization.
Esmaeilzadeh H; Zare M; Alyasin S; Nabavizadeh H; Mortazavi N; Kanannejad Z
Iran J Allergy Asthma Immunol; 2022 Oct; 21(5):512-523. PubMed ID: 36341560
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease.
Yong M; Wu YQ; Howlett J; Ballreich J; Walgama E; Thamboo A
Int Forum Allergy Rhinol; 2021 Dec; 11(12):1626-1636. PubMed ID: 34309219
[TBL] [Abstract][Full Text] [Related]
31. Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease.
Jean T; Eng V; Sheikh J; Kaplan MS; Goldberg B; Jau Yang S; Samant S
Allergy Asthma Proc; 2019 Sep; 40(5):316-320. PubMed ID: 31514790
[No Abstract] [Full Text] [Related]
32. Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations.
Levy JM; Rudmik L; Peters AT; Wise SK; Rotenberg BW; Smith TL
Int Forum Allergy Rhinol; 2016 Dec; 6(12):1273-1283. PubMed ID: 27480830
[TBL] [Abstract][Full Text] [Related]
33. Association Between Aspirin-Exacerbated Respiratory Disease and Atherosclerotic Cardiovascular Disease: A Retrospective Review of US Claims Data.
Adame MJ; Raji M; Shan Y; Zhang Y; Kuo YF; Tripple JW
J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3445-3453.e6. PubMed ID: 37468040
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
Stevens WW; Peters AT; Hirsch AG; Nordberg CM; Schwartz BS; Mercer DG; Mahdavinia M; Grammer LC; Hulse KE; Kern RC; Avila P; Schleimer RP
J Allergy Clin Immunol Pract; 2017; 5(4):1061-1070.e3. PubMed ID: 28286156
[TBL] [Abstract][Full Text] [Related]
35. Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: a systematic review.
Larivée N; Chin CJ
Int Forum Allergy Rhinol; 2020 Apr; 10(4):450-464. PubMed ID: 31951112
[TBL] [Abstract][Full Text] [Related]
36. Upper airways in aspirin-exacerbated respiratory disease.
Choi JH; Kim JH; Park HS
Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
[TBL] [Abstract][Full Text] [Related]
37. Chronic Rhinosinusitis Outcomes of Patients With Aspirin-Exacerbated Respiratory Disease Treated With Budesonide Irrigations: A Case Series.
Talat R; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
Ann Otol Rhinol Laryngol; 2022 Oct; 131(10):1130-1136. PubMed ID: 34775833
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulatory treatments for aspirin exacerbated respiratory disease.
Moebus RG; Han JK
Am J Rhinol Allergy; 2012; 26(2):134-40. PubMed ID: 22487291
[TBL] [Abstract][Full Text] [Related]
39. A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease.
Eid RC; Palumbo ML; Laidlaw TM; Buchheit KM; Cahill KN
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1338-1340. PubMed ID: 30261317
[No Abstract] [Full Text] [Related]
40. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
